TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-03
AKTIENPREIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership513,813 shares
Latest Disclosed Value $ 17,068,868
Squarepoint Ops LLC ownership in 1TGTX / TG Therapeutics, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 513,813 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $14,212,068 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 852,522 shares of TG Therapeutics, Inc.. This represents a change in shares of -39.73% during the quarter. The current value of the position is $17,469,642 USD.

Squarepoint Ops LLC has a history of taking positions in derivatives of the underlying security (1TGTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1TGTX / TG Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TG THERAPEUTICS COM 88322Q108 513,813 -338,709 -39.73 17,069 -32.84 0.0201
2026-02-13 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 852,522 347,888 68.94 25,414 39.41 0.0270
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 504,634 504,634 18,230 0.0183
2025-08-27 2025-06-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 0 -319,226 -100.00 0 -100.00
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 0 -319,226 0
2025-08-27 2025-03-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 319,226 108,431 51.44 12,587 98.41 0.0153
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 319,226 108,431 12,587 0.0153
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 210,795 162,082 332.73 6,345 456.98 0.0063
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 48,713 -2,998 -5.80 1,139 23.94 0.0018
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 51,711 -9,573 -15.62 920 -1.39 0.0015
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 61,284 -264,540 -81.19 932 -83.25 0.0016
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 325,824 254,749 358.42 5,565 836.87 0.0105
2023-11-14 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 71,075 71,075 594 0.0015
2023-08-14 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 0 -67,179 -100.00 0 -100.00
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 67,179 -15,954 -19.19 1,010 2.75 0.0041
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 83,133 -33,005 -28.42 983 42.88 0.0039
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 116,138 116,138 688 0.0035
2022-05-16 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 0 -13,279 -100.00 0 -100.00
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 13,279 13,279 252 0.0007
2020-08-14 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 0 -73,590 -100.00 0 -100.00
2020-05-15 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 73,590 73,590 724 0.0185
2019-11-14 2019-09-30 13F TG THERAPEUTICS COM 88322Q108 0 -35,696 -100.00 0 -100.00
2019-08-14 2019-06-30 13F TG THERAPEUTICS COM 88322Q108 35,696 9,621 36.90 309 47.14 0.0030
2019-05-15 2019-03-31 13F TG THERAPEUTICS COM 88322Q108 26,075 26,075 210 0.0022
2018-11-14 2018-09-30 13F TG THERAPEUTICS COM 88322Q108 0 -14,200 -100.00 0 -100.00
2018-08-14 2018-06-30 13F TG THERAPEUTICS COM 88322Q108 14,200 -19 -0.13 187 -7.43 0.0025
2018-05-15 2018-03-31 13F TG THERAPEUTICS COM 88322Q108 14,219 -3,755 -20.89 202 37.41 0.0032
2018-02-14 2017-12-31 13F TG THERAPEUTICS COM 88322Q108 17,974 17,974 147 0.0026
2017-05-15 2017-03-31 13F TG THERAPEUTICS COM 88322Q108 0 -39,605 -100.00 0 -100.00
2017-02-14 2016-12-31 13F TG THERAPEUTICS COM 88322Q108 39,605 39,605 0.00 184 0.0075
2016-05-16 2016-03-31 13F TG THERAPEUTICS COM 88322Q108 0 -23,500 -100.00 0 -100.00
2016-02-16 2015-12-31 13F TG THERAPEUTICS COM 88322Q108 23,500 23,500 280 0.0307
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TG THERAPEUTICS COM Call 0 -100.00 0 n/a n/a n/a
2026-02-13 2025-12-31 13F TG THERAPEUTICS COM Call 7,000 -20.45 209 -34.38 n/a n/a n/a
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM Call 8,800 -39.73 318 -39.62 n/a n/a n/a
2025-08-27 2025-06-30 13F/A TG THERAPEUTICS COM Call 14,600 -0.68 525 -9.33 n/a n/a n/a
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM Call 14,600 525 n/a n/a n/a
2025-08-27 2025-03-31 13F/A TG THERAPEUTICS COM Call 14,700 -70.24 580 -61.04 n/a n/a n/a
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM Call 14,700 580 n/a n/a n/a
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM Call 49,400 1,487 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM Put 13,800 22.12 499 22.66 n/a n/a n/a
2025-08-27 2025-06-30 13F/A TG THERAPEUTICS COM Put 11,300 -3.42 407 -11.93 n/a n/a n/a
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM Put 11,300 407 n/a n/a n/a
2025-08-27 2025-03-31 13F/A TG THERAPEUTICS COM Put 11,700 -80.43 461 -74.37 n/a n/a n/a
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM Put 11,700 461 n/a n/a n/a
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM Put 59,800 1,800 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.